Influence of dietary components on regulatory T cells

Molecular Medicine

Volumn 18, Issue 1, 2012, Pages 95-110

  Issazadeh Navikas, Shohreh ^a   Teimer, Roman ^a   Bockermann, Robert ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; COLECALCIFEROL DERIVATIVE; DOCOSAHEXAENOIC ACID; FATTY ACID; GLUTEN; INTERLEUKIN 10; PROBIOTIC AGENT; RETINOL DERIVATIVE; TRANSCRIPTION FACTOR FOXP3; VITAMIN D DERIVATIVE;

ALLERGY; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; ASTHMA; AUTOIMMUNITY; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM INFANTIS; CELL EXPANSION; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DAIRY PRODUCT; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DIETARY INTAKE; ENTERITIS; FOOD COMPOSITION; HOMEOSTASIS; HUMAN; ILEITIS; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INSULIN DEPENDENT DIABETES MELLITUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SALIVARIUS; LIPID DIET; LYMPHOCYTE FUNCTION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; TH17 CELL; TISSUE SPECIFICITY;

ANIMALS; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; T-LYMPHOCYTES, REGULATORY; VITAMINS;

EID: 84857006554     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00311     Document Type: Article

References (137)

1. Maloy KJ, Powrie F. (2001) Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816-22.
2. Ziegler SF. (2006) FOXP3: of mice and men. Annu. Rev. Immunol. 24:209-26.
3. Chen W, Konkel JE. 2010. TGF-beta and 'adaptive' Foxp3(+) regulatory T cells. J. Mol. Cell. Biol. 2:30-6.
4. Collison LW, et al. (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 450:566-9.
5. Collison LW, et al. (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11:1093-101.
6. Kim CH. (2006) Migration and function of FoxP3+ regulatory T cells in the hematolym-phoid system. Exp. Hematol. 34:1033-40.
7. Bennett CL, et al. (2001) The immune dysregula-tion, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20-1.
8. Brunkow ME, et al. (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68-73.
9. Curiel TJ. (2007) Tregs and rethinking cancer im-munotherapy. J. Clin. Invest. 117:1167-74.
10. Sakaguchi S. (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 101:455-8.
11. Curotto de Lafaille MA, Lafaille JJ. (2009) Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity. 30:626-35.
12. Liu Y, Teige I, Birnir B, Issazadeh-Navikas S. (2006) Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat. Med. 12:518-25.
13. Weiner HL, da Cunha AP, Quintana F, Wu H. (2011) Oral tolerance. Immunol. Rev. 241:241-59.
14. Liu Y, Teige I, Ericsson I, Navikas V, Issazadeh-Navikas S. (2010) Suppression of EAE by oral tolerance is independent of endogenous IFN-beta whereas treatment with recombinant IFN-beta ameliorates EAE. Immunol. Cell. Biol. 88:468-76.
15. Food and Agriculture Organization of the United Nations [FAO]; WHO. (2001) Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria: Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria: Amerian Córdoba Park Hotel, Córdoba, Argentina: 1-4 October 2001 [PDF on the Internet]. [Rome]: FAO; [Geneva]: WHO; [cited 2012 Jan 19]. Available from: www.who.int/entity/foodsafety/publications/fs_management/en/probiotics.pdf
16. Sartor RB. (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gas-troenterology. 126:1620-33.
17. Sartor RB. (2006) Mechanisms of disease: patho-genesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3:390-407.
18. Taurog JD, et al. (1994) The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180:2359-64.
19. Waidmann M, et al. (2003) Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gas-troenterology. 125:162-77.
20. Kwon HK, et al. (2010) Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probi-otics administration suppresses immune disorders. Proc. Natl. Acad. Sci. U. S. A. 107:2159-64.
21. Siddiqui KR, Powrie F. (2008) CD103+ GALT DCs promote Foxp3+ regulatory T cells. Mucosal Immunol. 1 Suppl 1:S34-8.
22. Izcue A, Coombes JL, Powrie F. (2006) Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212:256-71.
23. Ivanov II, et al. (2008) Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell. Host Microbe. 4:337-49.
24. Rad R, et al. (2006) CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology. 131:525-37.
25. O'Mahony C, et al. (2008) Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog. 4:e1000112.
26. So JS, et al. (2008) Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. Mol. Immunol. 46:172-80.
27. So JS, et al. (2008) Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. Mol. Immunol. 45:2690-9.
28. Kato I, Endo-Tanaka K, Yokokura T. (1998) Sup-pressive effects of the oral dministration of Lac-tobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Life Sci. 63:635-44.
29. Hacini-Rachinel F, et al. (2009) Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS One. 4:e4903.
30. Maassen CB, Claassen E. (2008) Strain-dependent effects of probiotic lactobacilli on EAE autoim-munity. Vaccine. 26:2056-7.
31. Ochoa-Reparaz J, et al. (2010) Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J. Immunol.185:4101-8.
32. Ochoa-Reparaz J, Mielcarz DW, Haque-Begum S, Kasper LH. (2010) Induction of a regulatory B cell population in experimental allergic en-cephalomyelitis by alteration of the gut commensal microflora. Gut Microbes. 1:103-108.
33. Kobayashi T, et al. (2010) Oral administration of probiotic bacteria, Lactobacillus casei and Bifi- dobacterium breve, does not exacerbate neuro logical symptoms in experimental autoimmune encephalomyelitis. Immunopharmacol. Immunotox-icol. 32:116-24.
34. Ezendam J, van Loveren H. (2008) Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice. Br. J. Nutr. 99:83-90.
35. Baken KA, et al. (2006) Evaluation of im-munomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression. Int. J. Food Microbiol. 112:8-18.
36. Rachmilewitz D, et al. (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gas-troenterology. 126:520-8.
37. Karimi K, Inman MD, Bienenstock J, Forsythe P. (2009) Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am. J. Respir. Crit. Care Med. 179:186-193.
38. Petrof EO, et al. (2004) Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology. 127:1474-87.
39. Petrof EO, et al. (2009) Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits protea-some function. Inflamm. Bowel Dis. 15:1537-47.
40. Cong Y, et al. (2005) Generation of antigen-specific, Foxp3-expressing CD4+ regulatory T cells by inhibition of APC proteosome function. J. Immunol. 174:2787-95.
41. Smits HH, et al. (2005) Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 115:1260-7.
42. Foligne B, et al. (2007) A key role of dendritic cells in probiotic functionality. PLoS One. 2:e313.
43. Rahman MK, et al. (2010) The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival. J. Immunol. 184:7247-56.
44. Penack O, et al. (2009) NOD2 regulates hematopoietic cell function during graft-versus-host disease. J. Exp. Med. 206:2101-10.
45. Petnicki-Ocwieja T, et al. (2009) Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. U. S. A. 106:15813-8.
46. Fernandez EM, et al. (2011) Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut. 60:1050-9.
47. Rachmilewitz D, et al. (2002) Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology. 122:1428-41.
48. Bleich A, et al. (2009) CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction. Gastroenterology. 136:278-87.
49. Bilsborough J, George TC, Norment A, Viney JL. (2003) Mucosal CD8alpha+ DC, with a plasmacy-toid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology. 108:481-92.
50. Zarek PE, et al. (2008) A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood. 111:251-9.
51. Mandapathil M, et al. (2010) Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J. Biol. Chem. 285:7176-86.
52. Atarashi K, et al. (2008) ATP drives lamina propria T(H)17 cell differentiation. Nature. 455:808-12.
53. Salmi M, Jalkanen S. (2001) Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J. Immunol. 166:4650-7.
54. Moran JP, Walter J, Tannock GW, Tonkonogy SL, Sartor RB. (2009) Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice. Inflamm. Bowel Dis. 15:1022-31.
55. Leach MW, Davidson NJ, Fort MM, Powrie F, Rennick DM. (1999) The role of IL-10 in inflammatory bowel disease: "of mice and men." Toxi-col. Pathol. 27:123-33.
56. Lee JS, Paek NS, Kwon OS, Hahm KB. (2010) Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling (SOCS) expression and signaling in Helicobacter pylori infection: a novel mechanism. J. Gastroen-terol. Hepatol. 25:194-202.
57. Pillemer BB, Xu H, Oriss TB, Qi Z, Ray A. (2007) Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function. Eur. J. Immunol. 37:2082-9.
58. Schmidt EG, Claesson MH, Jensen SS, Ravn P, Kristensen NN. (2010) Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bi-fidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity. Inflamm. Bowel Dis. 16:390-400.
59. Ertelt JM, et al. (2009) Selective priming and expansion of antigen-specific Foxp3- CD4+ T cells during Listeria monocytogenes infection. J. Immunol. 182:3032-8.
60. Kandulski A, et al. (2008) Naturally occurring regulatory T cells (CD4+, CD25high, FOXP3+) in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGF-beta1. Helicobacter. 13:295-303.
61. DeLuca HF. (2004) Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80:1689S-96S.
62. Belkaid Y, Oldenhove G. (2008) Tuning microen-vironments: induction of regulatory T cells by dendritic cells. Immunity. 29:362-71.
63. Matheu V, Back O, Mondoc E, Issazadeh-Navikas S. (2003) Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J. Allergy Clin. Immunol. 112:585-92.
64. Matheu V, et al. (2009) Impact on allergic immune response after treatment with vitamin A. Nutr. Metab. 6:44.
65. Penniston KL, Tanumihardjo SA. (2006) The acute and chronic toxic effects of vitamin A. Am. J. Clin. Nutr. 83:191-201.
66. Cantorna MT, Nashold FE, Hayes CE. (1994) In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J. Immunol. 152:1515-22.
67. Stephensen CB, et al. (2002) Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway. J. Immunol. 168:4495-503.
68. Kang SG, et al. (2007) Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J. Immunol. 179:3724-33.
69. Mucida D, et al. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 317:256-60.
70. Elias KM, et al. (2008) Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood. 111:1013-20.
71. Korn T, et al. (2007) Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13:423-31.
72. Racke MK, et al. (1995) Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course. J. Immunol. 154:450-8.
73. Massacesi L, et al. (1991) Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. J. Clin. Invest. 88:1331-7.
74. Massacesi L, et al. (1987) Suppression of experimental allergic encephalomyelitis by retinoic acid. J. Neurol. Sci. 80:55-64.
75. Xiao S, et al. (2008) Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181:2277-84.
76. Hall JA, Grainger JR, Spencer SP, Belkaid Y. (2011) The role of retinoic acid in tolerance and immunity. Immunity. 35:13-22.
77. Manicassamy S, et al. (2009) Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat. Med. 15:401-9.
78. White JH. (2011) Vitamin D metabolism and signaling in the immune system. Rev. Endocr. Metab. Disord. 2011, Aug 16. [Epub ahead of print].
79. Vieth R. (2004) Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. J. Steroid. Biochem. Mol. Biol. 89-90:575-9.
80. Ghoreishi M, et al. (2009) Expansion of antigen-specific regulatory T cells with the topical vitamin D analog calcipotriol. J. Immunol. 182:6071-8.
81. Ghoreishi M, Dutz J P. (2006) Tolerance induction by transcutaneous immunization through ultra-violet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10. J. Immunol. 176:2635-44.
82. Spach KM, Hayes CE. (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J. Immunol. 175:4119-26.
83. Horst RL, Reinhardt TA, Ramberg CF, Koszewski NJ, Napoli JL. (1986) 24-Hydroxylation of 1,25-dihydroxyergocalciferol: an unambiguous deacti-vation process. J. Biol. Chem. 261:9250-6.
84. Nashold FE, Spach KM, Spanier JA, Hayes CE. (2009) Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalo -myelitis by controlling vitamin D3 metabolism and receptor expression. J. Immunol. 183:3672-81.
85. Jeffery LE, et al. (2009) 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 183:5458-67.
86. Driver J P, Foreman O, Mathieu C, van Etten E, Ser-reze D V. (2008) Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D(3) and 1alpha-hydroxyvitamin D(3) on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet. Clin. Exp. Immunol. 151:76-85.
87. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. (2002) A 1alpha,25-dihydroxyvita-min D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 51:1367-74.
88. Barrat FJ, et al. (2002) In vitro generation of inter-leukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195:603-16.
89. Vieira PL, et al. (2004) IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 172:5986-93.
90. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. (2008) Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with cal-citriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 324:23-33.
91. Gorman S, Judge MA, Burchell JT, Turner DJ, Hart PH. (2010) 1,25-dihydroxyvitamin D3 enhances the ability of transferred CD4+ CD25+ cells to modulate T helper type 2-driven asthmatic responses. Immunology. 130:181-92.
92. Hewison M, et al. (2007) Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J. Steroid. Biochem. Mol. Biol. 103:316-21.
93. Sigmundsdottir H, et al. (2007) DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat. Immunol. 8:285-93.
94. Correale J, Ysrraelit MC, Gaitan MI. (2009) Im-munomodulatory effects of vitamin D in multiple sclerosis. Brain. 132:1146-60.
95. Meehan TF, DeLuca HF. (2002) The vitamin D receptor is necessary for 1alpha,25-dihydroxyvi-tamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Arch. Biochem. Biophys. 408:200-4.
96. Smolders J, et al. (2009) Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One. 4:e6635.
97. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 296:2832-8.
98. Zhou X, et al. (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10:1000-7.
99. Green PH, Cellier C. (2007) Celiac disease. N. Engl. J. Med. 357:1731-43.
100. Frisullo G, et al. (2009) Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. Hum. Immunol. 70:430-5.
101. Funda DP, Kaas A, Bock T, Tlaskalova-Hogenova H, Buschard K. (1999) Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab. Res. Rev. 15:323-7.
102. Lefebvre DE, Powell KL, Strom A, Scott FW. (2006) Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Annu. Rev. Nutr. 26:175-202.
103. Schmid S, et al. (2004) Delayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice. Clin. Immunol. 111:108-18.
104. Ejsing-Duun M, Josephsen J, Aasted B, Buschard K, Hansen AK. (2008) Dietary gluten reduces the number of intestinal regulatory T cells in mice. Scand. J. Immunol. 67:553-9.
105. Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R. (2005) Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes. J. Exp. Med. 201:1333-46.
106. Kivling A, et al. (2008) Diverse foxp3 expression in children with type 1 diabetes and celiac disease. Ann. N. Y. Acad. Sci. 1150:273-7.
107. Di Marco R, et al. (2004) Exacerbation of protracted-relapsing experimental allergic en-cephalomyelitis in DA rats by gluten-free diet. APMIS. 112:651-5.
108. Du Pre MF, et al. (2011) Tolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T cells. Gastroenterol-ogy. 141:610-620, e611-612.
109. McNamara RK, et al. (2007) Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol. Psychiatry. 62:17-24.
110. Serhan CN, Gotlinger K, Hong S, Arita M. (2004) Resolvins, docosatrienes, and neuropro-tectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat. 73:155-72.
111. El-Mesery M, Al-Gayyar M, Salem H, Darweish M, El-Mowafy A. (2009) Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides. Cell Div. 4:6.
112. Kato T, et al. (2002) Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice. Cancer Lett. 187:169-77.
113. Schonberg SA, et al. (2006) Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids, accumulate different lipid classes and downregulate sterol regulatory element-binding protein 1. FEBS J. 273:2749-65.
114. Shaikh IA, Brown I, Schofield AC, Wahle KW, Heys SD. (2008) Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway. Prostate. 68:1635-46.
115. + regulatory T-cells. J Lipid Res. 50:2377-88.
116. Shevach EM. (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389-400.
117. Sebastiani S, et al. (2001) Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J. Immunol. 166:996-1002.
118. Kong W, Yen JH, Ganea D. (2011) Docosa-hexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis. Brain Behave. Immun. 25:872-82.
119. Tran DQ, Ramsey H, Shevach EM. (2007) Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory pheno-type. Blood. 110:2983-90.
120. Chang KM. (2005) Regulatory T cells and the liver: a new piece of the puzzle. Hepatology. 41:700-2.
121. Winer S, et al. (2009) Normalization of obesity-associated insulin resistance through im-munotherapy. Nat. Med. 15:921-9.
122. Ma X, et al. (2007) A high-fat diet and regulatory T cells influence susceptibility to endotoxin-in-duced liver injury. Hepatology. 46:1519-29.
123. Hildeman DA, et al. (1999) Reactive oxygen species regulate activation-induced T cell apo-ptosis. Immunity. 10:735-44.
124. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:241-51.
125. Laurent A, et al. (2004) Pivotal role of superox-ide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology. 39:1277-85.
126. Roselli M, et al. (2009) Prevention of TNBS- induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm. Bowel Dis. 15:1526-36.
127. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bear-ing regulatory cells. J. Immunol. 174:3237-46.
128. Pronio A, et al. (2008) Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm. Bowel Dis. 14:662-8.
129. Sheil B, et al. (2004) Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut. 53:694-700.
130. Baharav E, Mor F, Halpern M, Weinberger A. (2004) Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J. Nutr. 134:1964-9.
131. Lavasani S, et al. (2010) A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One. 5:e9009.
132. Feleszko W, et al. (2007) Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin. Exp. Allergy. 37:498-505.
133. Sun CM, et al. (2007) Small intestine lamina pro-pria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204:1775-85.
134. Coombes JL, et al. (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204:1757-64.
135. Royal W 3rd, Mia Y, Li H, Naunton K. (2009) Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. J. Neuroim-munol. 213:135-41.
136. Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO. (2009) Induction of Treg by monocyte-derived DC modulated by vitamin D(3) or dexamethasone: differential role for PD-L1. Eur. J. Immunol. 39:3147-59.
137. Cipolletta D, Kolodin D, Benoist C, Mathis D. (2011) Tissular Tregs: a unique population of adipose-tissue-resident Foxp3+CD4+ T cells that impacts organismal metabolism. Semin. Immunol. 23:431-7.